Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage: Version 3

Mutation Research - DNA Repair

Volumn 433, Issue 2, 1999, Pages 69-87

  Friedberg, Errol C ^a   Meira, Lisiane B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ANIMAL CELL; ANIMAL EXPERIMENT; DATA BASE; DNA DAMAGE; EXCISION REPAIR; GENE MUTATION; KNOCKOUT MOUSE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0033028851     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(98)00068-8     Document Type: Article

References (81)

1. Friedberg E.C., Meira L.B., Cheo D.L. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage: version 2. Mutat. Res. 407:1998;217-226.
2. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase β gene segment in T-cells using cell type-specific gene targeting. Science. 265:1994;103-106.
3. Xanthoudakis S., Smeyne R.J., Wallace J.D., Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. USA. 93:1996;8919-8923.
4. L.B. Meira, E.C. Friedberg, unpublished observations.
5. Ludwig D.L., MacInnes M.A., Takiguchi Y., Purtymun P.E., Henrie M., Flannery M., Meneses J., Pedersen R.A., Chen D.J. A murine AP-endonuclease gene-targeted deficiency with postimplantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 409:1998;17-29.
6. Bentley D.J., Selfridge J., Millar J.K., Samuel K., Hole N., Ansell J.D., Melton D.W. DNA ligase I is required for fetal liver development but is not essential for mammalian cell viability. Nature Genetics. 13:1996;489-491.
7. A. Kluglund, T. Lindahl, E. Seeberg, D. Barnes, personal communication.
8. H. Nilsen, H. Krokan, T. Lindahl, D. Barnes, personal communication.
9. Engelward B.P., Weeda G., Wyatt M.D., Broekhof J.L.M., de Wit J., Donker I., Allan J.M., Gold B., Hoeijmakers J.H.J., Samson L.D. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl Acad. Sci. USA. 94:1997;13087-13092.
10. 4-ethanocytosine or 8-oxyguanine. Proc. Natl Acad. Sci. USA. 94:1997;12869-12874.
11. Elder R.H., Jansen J.G., Weeks R.J., Willington M.A., Deans B., Watson A.J., Mynett K.J., Bailey J.A., Cooper D.P., Rafferty J.A., Heeran M.C., Wijnhoven S.W.P., van Zeeland A.A., Margison G.P. Alkyl-DNA-N-glycosylase knock-out mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol. Cell. Biol. 18:1998;5828-5837.
12. McWhir J., Selfridge J., Harrison D.J., Squires S., Melton D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genetics. 5:1993;217-223.
13. Weeda G., Donker I., de Wit J., Morreau H., Visser C.J., Nigg A.L., Janssens R., van Steeg H., Dortant P.M., Bootsma D., Hoeijmakers J.H.J. Disruption of the mouse ERCC1 endonuclease results in a novel DNA repair syndrome with growth failure, nuclear abnormalities in liver and kidney and signs of premature senescence. Curr. Biol. 7:1997;427-439.
14. de Vries A., van Ostrom C.Th.M., Hofhuis F.M.A., Dortant P.M., Berg R.J.W., de Gruijl F.R., Wester P.W., van Kreijl C.F., Capel P.J.A., van Steeg H., Verbeek S.J. Increased susceptibility to ultraviolet-B and carcinogenesis in mice lacking the DNA repair gene XPA. Nature. 377:1995;169-173.
15. Nakane H., Takeuchi S., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y., Kato Y., Tsunoda Y., Miyauchi H., Horio T., Tokunaga T., Matsunaga T., Nikaido O., Nishimune Y., Okada Y., Tanaka K. High incidence of ultraviolet-B or chemical carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature. 377:1995;165-168.
16. Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature. 377:1995;162-165.
17. Cheo D.L., Ruven H.J.T., Meira L.B., Hammer R.E., Burns D.K., Tappe N.J., van Zeeland A.A., Mullenders L.H.F., Friedberg E.C. Characterization of defective nucleotide excision repair in XPC mutant mice generated by targeted gene replacement. Mutat. Res. 374:1997;1-9.
18. Cheo D.L., Meira L.B., Hammer R.E., Burns D.K., Doughty A.T.B., Friedberg E.C. Synergistic interactions between XPC and p53 mutations in double mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr. Biol. 6:1996;691-1694.
19. Meira L.B., Cheo D.L., Reis A., Hammer R.E., Burns D.K., Friedberg E.C. Genetic interaction between HAP1(REF-1) and p53. Nature Genetics. 17:1997;145.
20. G. Weeda, I. Donker, J.L.M. Broekhof, J. de Wit, J.H.J. Hoeijmakers, Lethal and viable targeted mutations in the basal transcription/DNA repair helicase XPB: a mouse model for the human repair disorder xeroderma pigmentosum, manuscript in preparation.
21. de Boer J., Donker I., de Wit J., Hoeijmakers J.H.J., Weeda G. Disruption of the XPD DNA repair/transcription gene results in preimplantation embryonic lethality. Cancer Res. 58:1998;89-94.
22. de Boer J., de Wit J., van Steeg H., Berg R.J.W., Morreau H., Visser P., Lehmann A.R., Duran M., Hoeijmakers J.H.J., Weeda G. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Molecular Cell. 1:1998;981-990.
23. Y.-N. Harada, N. Shiomi, M. Koike, M. Ikawa, M. Okabe, S. Hirota, Y. Kitamura, M. Kitagawa, T. Matsunaga, O. Nakaido, T. Shiomi, Post-natal growth failure, a short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene, manuscript submitted.
24. T. Shiomi, personal communication.
25. J. Ng, K. Sugasawa, G.T.J. van der Horst, J.H.J. Hoeijmakers et al., manuscript in preparation.
26. J. Ng, K. Sugasawa, H. Vrieling, J.H.J. Hoeijmakers, G.T.J. van der Horst et al., manuscript in preparation.
27. G.T.J. van der Horst, K. Henning, E.C. Friedberg, J.H.J. Hoeijmakers et al., unpublished observations.
28. van der Horst G.T.J., van Steeg H., Berg R.J.W., van Gool A.J., de Wit J., Weeda G., Morreau H., Beems R.B., van Kreijl C.F., de Gruijl F.R., Bootsma D., Hoeijmakers J.H.J. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
29. G.T.J. van der Horst, H. van Steeg, K. Tanaka, A. Bradley, J.H.J. Hoeijmakers et al., manuscript in preparation.
30. Prolla T.A., Baker S.M., Harris A.C., Tsao J.-L., Yao X., Bronner C.E., Zheng B., Gordon M., Reneker J., Arnheim N., Shibata D., Bradley A., Liskay R.M. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nature Genetics. 18:1998;276-279.
31. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N., Flavell R.A., Liskay R.M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
32. -/-; Min mice. Cancer Res. 58:1998;1087-1089.
33. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82:1995;321-330.
34. Reitmair A.H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.-W., Wakeham A., Liu B., Thomason A., Griesser H., Gallinger S., Ballhausen W.G., Fishel R., Mak T.W. MSH2 deficient mice are viable and susceptible to lymphoid tumors. Nature Genetics. 11:1995;64-70.
35. Reitmair A.H., Cai J.-C., Bjerknes M., Redston M., Cheng H., Pind M.T.L., Hay K., Mitri A., Bapat B.V., Mak T.W., Gallinger S. MSH2 deficiency contributes to APC-mediated intestinal tumorigenesis. Cancer Res. 56:1996;2922-2926.
36. de Wind N., Dekker M., van Rossum A., van der Valk M., te Riele H. Mouse models for hereditary non-polyposis colorectal cancer. Cancer Res. 58:1998;248-255.
37. Cranston A., Bocker T., Reitmair A., Palazzo J., Wilson T., Mak T., Fishel R. Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nature Genetics. 17:1997;114-118.
38. Toft N.J., Arends M.J., Wyllie A.H., Clarke A.R. No female embryonic lethality in mice nullizygous for Msh2 and p53. Nature Genetics. 18:1998;17.
39. D.L. Cheo, L.B. Meira, H. te Riele, E.C. Friedberg, unpublished observations.
40. Edelman W., Yang K., Umar A., Heyer J., Lau K., Fan K., Liedtke W., Cohen P.E., Kane M.F., Lipford J.R., Yu N., Crouse G.F., Pollard J.W., Kunkel T., Lipkin M., Kolodner R., Kucherlapati R. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell. 91:1997;467-477.
41. Baker S.M., Plug A.W., Prolla T.A., Bronner C.E., Harris A.E., Yao X., Christie D.-M., Monell C., Arnheim N., Bradley A., Ashley T., Liskay R.M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nature Genetics. 13:1996;336-342.
42. Edelmann W., Cohen P.E., Kane M., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard J.W., Kolodner R.D., Kucherlapati R. Meiotic pachytene arrest in MLH1-deficient mice. Cell. 85:1996;1125-1134.
43. Tsuzuki T., Sakumi K., Shiraishi A., Kawate H., Igarashi H., Iwakuma T., Tominaga Y., Zhang S., Shimizu S., Ishikawa T., Nakamura K., Nakao K., Katsuki M., Sekiguchi M. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis. 17:1996;1215-1220.
44. B. Glassner, B.P. Engelward, L. Samson, J.H.J. Hoeijmakers, G. Weeda, unpublished observations.
45. Kawate H., Sakumi K., Tsuzuki T., Nakatsuru Y., Ishikawa T., Takahashi S., Takano H., Noda T., Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl. Acad. Sci USA. 95:1998;5116-5120.
46. R.S. Tebbs, M.L. Flannery, J.J. Meneses, A. Hartman, J.D. Tucker, L.H. Thompson, J.E. Cleaver, R.A. Pederson, Requirement for the Xrcc1 DNA Repair Gene During Early Mouse Development, manuscript submitted.
47. Zhu C., Bogue M.A., Lim D.-S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.
48. Nussenzweig A., Chen C., de Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
49. Ouyang H., Nussenzweig A., Kurimasa A., de Costa Soares V., Li X., Cordon-Cardo C., Li W.-H., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., Li G.C. Ku70 is required for DNA repair but not for T-cell antigen receptor gene recombination in vivo. J. Exp. Med. 186:1997;921-929.
50. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der Stoep N., Davidson L., Cheng H.-L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 7:1997;653-665.
51. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.-L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 396:1998;173-177.
52. D.E. Barnes, G. Stamp, I. Rosewell, A. Denzel, T. Lindahl, Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice, Curr. Biol., 1998, in press.
53. Taccioli G.E., Amatucci A.A., Beamish H.J., Gell D., Xiang X.H., Torres Arzayus M.I., Priestley A., Jackson S.P., Marshak Rothstein A., Jeggo P.A., Herrera V.L.M. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity. 9:1998;355-356.
54. Wang Z.-Q., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E.F. Mice lacking ADPRT and poly(ADP)-ribosylation develop normally but are susceptible to skin disease. Genes Dev. 9:1995;509-520.
55. de Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F.J., Masson M., Dierich A., LeMeur M., Walztinger C., Chambon P., de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA. 94:1997;7303-7307.
56. Morrison C., Smith G.C.M., Stingl L., Jackson S.P., Wagner E.F., Wang Z.-Q. Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nature Genetics. 17:1997;479-482.
57. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA. 93:1996;6236-6240.
58. Lim D.-S., Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16:1996;7133-7143.
59. Rijkers T., van den Ouweland J., Morolli B., Rolink A.G., Baarends W.M., van Sloun P.P.H., Lohman P.H.M., Pastink A. Targeted inactivation of mouse RAD52 reduces homologous recombination but not resistance to ionizing radiation. Mol. Cell. Biol. 18:1998;6423-6429.
60. Essers J., Hendriks R.W., Swagemakers S.M.A., Troelstra C., de Wit J., Bootsma D., Hoeijmakers J.H.J., Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
61. Liu C.-Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W.-H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1996;1835-1843.
62. Sharan S.K., Morimatsu M., Albrecht U., Lim D.-S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386:1997;804-810.
63. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
64. Suzuki A., de la Pompa J.L., Hakem R., Elia A., Yoshida R., Mo R.et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1997;1242-1252.
65. Connor F., Bertwistle D., Mee P.J., Ross G.M., Swift S., Grigorieva E., Tybulewicz V.L.J., Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nature Genetics. 17:1997;423-430.
66. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
67. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S.-I., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo I., Ikawa Y., Aizawa S. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 8:1993;3313-3322.
68. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
69. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
70. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:1996;159-171.
71. Xu Y., Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10:1996;2401-2410.
72. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:1996;2411-2422.
73. Barlow C., Liyanage M., Moens B.P., Deng C.-X., Ried T., Wynshaw-Boris A. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nature Genetics. 17:1997;462-466.
74. Barlow C., Brown K.D., Deng C.-X., Tagle D.A., Wynshaw-Boris A. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nature Genetics. 17:1997;453-456.
75. Wang Y.A., Elson A., Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;14590-14595.
76. Xu Y., Yang E.M., Brugarolas J., Jacks T., Baltimore D. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice. Mol. Cell. Biol. 18:1998;4385-4390.
77. Serrano M., Lee H.-W., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
78. H.P. Roest, J.H.J. Hoeijmakers et al., unpublished observations.
79. Roest H.P., van Klaveren J., de Wit J., van Gurp C.G., Koken M.H.M., Vermey M., van Roijen J.H., Hoogerbrugge J.W., Vreeburg J.T.M., Baarends W.M., Bootsma D., Grootegoed J.A., Hoeijmakers J.H.J. Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell. 86:1996;799-810.
80. Chen M., Tomkins D.J., Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos C.J., Freedman M.H., Cross J., Percy D.H., Dick J.E., Joyner A.L., Buchwald M. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia. Nature Genetics. 12:1996;448-451.
81. Whitney M.A., Royle G., Low M.J., Kelly M.A., Axthelm M.K., Reifsteck C., Olson S., Braun R.E., Heinrich M.C., Rathbun R.K., Bagby G.C., Grompe M. Germ cell defects and hemopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 88:1996;49-58.